Celon Pharma S.A. (CLN.WA)
PLN 25.35
(0.2%)
PLN 25.35
(0.2%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -8.31 Million | -4.7 Million | 43.95 Million | 70.9 Million | -5.05 Million | 28.24 Million |
| Net Income | -19.96 Million | -36.44 Million | -15.08 Million | 21.49 Million | 11.93 Million | 29.69 Million |
| Depreciation & Amortization | 50.01 Million | 44.09 Million | 41.34 Million | 30.88 Million | 20.62 Million | 17.21 Million |
| Deferred income taxes | - | -309 Thousand | -174 Thousand | - | - | - |
| Stock-based compensation | - | 309 Thousand | 174 Thousand | - | - | - |
| Change in working capital | -31.11 Million | -8.6 Million | 14.07 Million | 17.71 Million | -37.1 Million | -18.29 Million |
| Other non-cash items | 2.67 Million | -3.75 Million | 3.62 Million | 815 Thousand | -503.83 Thousand | -375.74 Thousand |
| Investing Cash Flow | -21.64 Million | -31.47 Million | -121.04 Million | -98.53 Million | -67.73 Million | -72.74 Million |
| Investments in PPE | -32.81 Million | -33.9 Million | -41.35 Million | -99.16 Million | -64.95 Million | -67.45 Million |
| Acquisitions | 1.23 Million | 587 Thousand | 171 Thousand | 631 Thousand | -10 Thousand | 341.86 Thousand |
| Investment purchases | - | - | -79.86 Million | -46.06 Million | -10 Thousand | - |
| Sales/Maturities of investments | 9.5 Million | - | -171 Thousand | 45.43 Million | 10 Thousand | - |
| Other Investing Activities | 62 Thousand | 1.84 Million | 171 Thousand | 631 Thousand | -2.77 Million | -5.28 Million |
| Financing Cash Flow | -20.58 Million | -28.72 Million | 180.91 Million | 4.91 Million | -8.51 Million | -8.85 Million |
| Debt repayment | -12.75 Million | -12.42 Million | -12.83 Million | -12.83 Million | -1.14 Million | -1.3 Million |
| Dividends payments | -4.59 Million | -14.8 Million | -3.15 Million | -3.6 Million | -7.2 Million | -7.65 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 2000.00 | 4000.00 | 216 Million | - | - | - |
| Other Financing Activities | -2.62 Million | -13.92 Million | -19.09 Million | 21.35 Million | -1.31 Million | -1.2 Million |
| Accounts receivables | -12.54 Million | -6.45 Million | 13.24 Million | 2.41 Million | -5.64 Million | -6.39 Million |
| Accounts payables | -6.94 Million | 10.24 Million | -10.17 Million | 14.48 Million | -1.57 Million | 1.78 Million |
| Inventory | 11.98 Million | -15 Million | 6.38 Million | 302 Thousand | -6.45 Million | -5.25 Million |
| Other working capital | -30.55 Million | 2.62 Million | 4.61 Million | 502 Thousand | -23.42 Million | -13.04 Million |
| Cash at beginning of period | 82.9 Million | 147.79 Million | 43.97 Million | 66.69 Million | 147.99 Million | 201.35 Million |
| Cash at end of period | 32.35 Million | 82.9 Million | 147.79 Million | 43.97 Million | 66.69 Million | 147.99 Million |
| Capital Expenditure | -32.81 Million | -33.9 Million | -41.35 Million | -99.16 Million | -64.95 Million | -67.45 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -50.54 Million | -64.89 Million | 103.81 Million | -22.71 Million | -81.3 Million | -53.35 Million |
| Free Cash Flow | -41.12 Million | -38.6 Million | 2.6 Million | -28.25 Million | -70 Million | -39.21 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -10.35 Million | -15.67 Million | -19.96 Million | -7.41 Million | -8.07 Million | 7.08 Million |
| Depreciation & Amortization | 12.43 Million | 12.72 Million | 50.01 Million | 12.78 Million | 12.75 Million | 12.7 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -13.45 Million | -172 Thousand | -31.11 Million | 12 Million | -3.58 Million | -25.63 Million |
| Other non-cash items | 518 Thousand | 20.04 Million | 2.67 Million | 945 Thousand | 7.01 Million | -1.82 Million |
| Investing Cash Flow | -8.32 Million | 9.34 Million | -21.64 Million | 3.4 Million | -5.72 Million | -11.42 Million |
| Investments in PPE | -3.94 Million | -652 Thousand | -32.81 Million | -6.59 Million | -5.99 Million | -11.76 Million |
| Acquisitions | -3.93 Million | - | 1.23 Million | 387 Thousand | 258 Thousand | 314 Thousand |
| Investment purchases | -20 Million | -10 Million | - | - | - | - |
| Sales/Maturities of investments | 20 Million | 20 Million | 9.5 Million | 9.5 Million | - | - |
| Other Investing Activities | -4.38 Million | 10.03 Million | 62 Thousand | 9.99 Million | 6000.00 | 23 Thousand |
| Financing Cash Flow | 25.05 Million | -3.25 Million | -20.58 Million | -371 Thousand | -5.52 Million | -5.66 Million |
| Debt repayment | -12.52 Million | -224 Thousand | -12.75 Million | -12.75 Million | -4.87 Million | -4.98 Million |
| Dividends payments | - | - | -4.59 Million | -4.59 Million | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 40.5 Million | - | 2000.00 | - | - | 2000.00 |
| Other Financing Activities | 27.21 Million | -838 Thousand | -2.62 Million | 12.19 Million | -644 Thousand | -5.67 Million |
| Accounts receivables | -16.76 Million | 6.43 Million | -12.54 Million | -1.59 Million | -1.7 Million | -8.89 Million |
| Accounts payables | - | -803 Thousand | -6.94 Million | 787 Thousand | -3.46 Million | 8.89 Million |
| Inventory | 2.91 Million | -2.82 Million | 11.98 Million | 3.4 Million | 546 Thousand | 8.01 Million |
| Other working capital | 398 Thousand | -2.98 Million | -30.55 Million | 10.18 Million | 1.03 Million | -33.64 Million |
| Cash at beginning of period | 32.73 Million | 32.35 Million | 82.9 Million | 21.91 Million | 25.06 Million | 49.81 Million |
| Cash at end of period | 45.12 Million | 32.73 Million | 32.35 Million | 32.35 Million | 21.91 Million | 25.06 Million |
| Capital Expenditure | -3.94 Million | -652 Thousand | -32.81 Million | -6.59 Million | -5.99 Million | -11.76 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 12.39 Million | 379 Thousand | -50.54 Million | 10.44 Million | -3.14 Million | -24.75 Million |
| Free Cash Flow | -8.27 Million | -6.36 Million | -41.12 Million | 821 Thousand | 2.11 Million | -19.42 Million |
ENTRINT
JETAIRWAYS
290650
DGE
GUER
AGYTF